全文获取类型
收费全文 | 245855篇 |
免费 | 22570篇 |
国内免费 | 17344篇 |
专业分类
耳鼻咽喉 | 2082篇 |
儿科学 | 2404篇 |
妇产科学 | 3271篇 |
基础医学 | 29518篇 |
口腔科学 | 4108篇 |
临床医学 | 34578篇 |
内科学 | 36674篇 |
皮肤病学 | 2431篇 |
神经病学 | 13785篇 |
特种医学 | 9040篇 |
外国民族医学 | 148篇 |
外科学 | 24095篇 |
综合类 | 39939篇 |
现状与发展 | 59篇 |
一般理论 | 21篇 |
预防医学 | 14648篇 |
眼科学 | 7696篇 |
药学 | 25635篇 |
217篇 | |
中国医学 | 13929篇 |
肿瘤学 | 21491篇 |
出版年
2024年 | 783篇 |
2023年 | 3979篇 |
2022年 | 10318篇 |
2021年 | 12816篇 |
2020年 | 9593篇 |
2019年 | 8446篇 |
2018年 | 8880篇 |
2017年 | 7984篇 |
2016年 | 7440篇 |
2015年 | 11481篇 |
2014年 | 13973篇 |
2013年 | 11902篇 |
2012年 | 17870篇 |
2011年 | 19984篇 |
2010年 | 11772篇 |
2009年 | 9188篇 |
2008年 | 12437篇 |
2007年 | 12394篇 |
2006年 | 12586篇 |
2005年 | 12863篇 |
2004年 | 7842篇 |
2003年 | 7345篇 |
2002年 | 6182篇 |
2001年 | 5533篇 |
2000年 | 5918篇 |
1999年 | 6354篇 |
1998年 | 3994篇 |
1997年 | 3932篇 |
1996年 | 3155篇 |
1995年 | 2931篇 |
1994年 | 2412篇 |
1993年 | 1566篇 |
1992年 | 2101篇 |
1991年 | 1787篇 |
1990年 | 1458篇 |
1989年 | 1224篇 |
1988年 | 1149篇 |
1987年 | 987篇 |
1986年 | 812篇 |
1985年 | 580篇 |
1984年 | 362篇 |
1983年 | 262篇 |
1982年 | 157篇 |
1981年 | 162篇 |
1980年 | 116篇 |
1979年 | 147篇 |
1978年 | 49篇 |
1977年 | 53篇 |
1975年 | 57篇 |
1974年 | 56篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
Jianhui Su Chaoyang Ma Chengxiang Liu Chuanzhong Gao Rongjing Nie 《International journal of food sciences and nutrition》2016,67(1):20-28
This study investigated the hypocholesterolaemic effects of bitter melon aqueous extracts (BMAE) in vitro, the inhibitory effects of BMAE on pancreatic cholesterol esterase (CEase) and incorporation of cholesterol into micelles were investigated. BMAE decreased the in vitro micellar solubility of cholesterol in a dose-dependent manner. The conformation of CEase was investigated by means of circular dichroism (CD) and fluorescence. The result revealed the decrease of α-helix contents, increase of β-sheet and exposure of aromatic amino acid residuals. The incorporation of cholesterol into micelles was inhibited by BMAE. A complex was observed by transmission electron microscopy (TEM), which indicated interaction between cholesterol and BMAE. The result revealed that BMAE can play a role in decreased intestinal cholesterol absorption via inhibition of CEase, and of micelle formation. 相似文献
4.
E. Niclas Jonsson Rujia Xie Scott F. Marshall Rosalin H. Arends 《British journal of clinical pharmacology》2016,81(4):688-699
AimsThe aims were to 1) develop the pharmacokinetics model to describe and predict observed tanezumab concentrations over time, 2) test possible covariate parameter relationships that could influence clearance and distribution and 3) assess the impact of fixed dosing vs. a dosing regimen adjusted by body weight.MethodsIndividual concentration–time data were determined from 1608 patients in four phase 3 studies conducted to assess efficacy and safety of intravenous tanezumab. Patients received two or three intravenous doses (2.5, 5 or 10 mg) every 8 weeks. Blood samples for assessment of tanezumab PK were collected at baseline, 1 h post‐dose and at weeks 4, 8, 16 and 24 (or early termination) in all studies. Blood samples were collected at week 32 in two studies. Plasma samples were analyzed using a sensitive, specific, validated enzyme‐linked immunosorbent assay.ResultsA two compartment model with parallel linear and non‐linear elimination processes adequately described the data. Population estimates for clearance (CL), central volume (V
1), peripheral volume (V
2), inter‐compartmental clearance, maximum elimination capacity (VM) and concentration at half‐maximum elimination capacity were 0.135 l day–1, 2.71 l, 1.98 l, 0.371 l day–1, 8.03 μg day–1 and 27.7 ng ml–1, respectively. Inter‐individual variability (IIV) was included on CL, V
1, V
2 and VM. A mixture model accounted for the distribution of residual error. While gender, dose and creatinine clearance were significant covariates, only body weight as a covariate of CL, V
1 and V
2 significantly reduced IIV.ConclusionsThe small increase in variability associated with fixed dosing is consistent with other monoclonal antibodies and does not change risk : benefit. 相似文献
5.
Dan-Feng Xu Bing Wu Jin-Xin Wang Jian Yu Jian-Xin Xie 《World Journal of Clinical Cases》2021,9(5):1096-1102
BACKGROUNDGuillain-Barré syndrome (GBS) is a rare disorder that typically presents with ascending weakness, pain, paraesthesias, and numbness, which mimic the findings in lumbar spinal stenosis. Here, we report a case of severe lumbar spinal stenosis combined with GBS.CASE SUMMARYA 70-year-old man with a history of lumbar spinal stenosis presented to our emergency department with severe lower back pain and lower extremity numbness. Magnetic resonance imaging confirmed the diagnosis of severe lumbar spinal stenosis. However, his symptoms did not improve postoperatively and he developed dysphagia and upper extremity numbness. An electromyogram was performed. Based on his symptoms, physical examination, and electromyogram, he was diagnosed with GBS. After 5 d of intravenous immunoglobulin (0.4 g/kg/d for 5 d) therapy, he gained 4/5 of strength in his upper and lower extremities and denied paraesthesias. He had regained 5/5 of strength in his extremities when he was discharged and had no symptoms during follow-up.CONCLUSIONGBS should be considered in the differential diagnosis of spinal disorder, even though magnetic resonance imaging shows severe lumbar spinal stenosis. This case highlights the importance of a careful diagnosis when a patient has a history of a disease and comes to the hospital with the same or similar symptoms. 相似文献
6.
7.
8.
9.
10.